NHS National Generics Pharmaceuticals Transition 2023_1
Estimated value
—
Awarded value
—
Suppliers
37
Lots
2
Published
24 May 2023
Description
Framework agreement for NHS National Generics Pharmacuticals Transition 2023_1. Offer reference number CM/PHG/22/5666.<br/><br/>Potential periods of call-offs under the framework agreement:<br/> CM/PHG/22/5666/00 – Transition Products:<br/>CESW- /08/2023 – 31/01/2024 (6 months) <br/>NWLN 01/08/2023 – 31/01/2025 (18 months)<br/>LSNE 01/08/2023 – 31/05/2024 (10 months) <br/> <br/>CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products: <br/>All regions: 01/08/2023 to 31/05/2024 (10 Months)
Scope
- Reference
- CM/PHG?22?5666
- Commercial tool
- Standalone contract
- Contract dates
- 31 Jul 2023 to 01 May 2024
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 37 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Lot 1 - CM/PHG/22/5666/00 - Supplier offer confirmation (Check box) | — | cancelled |
| 2 | Lot 2 - CM/PHG/22/5666/01 - Supplier offer confirmation (Check box) | — | cancelled |